Feb 1 (Reuters) - Australian Pharmaceutical Industries:
- DISCONTINUANCE OF CLASS ACTION AGAINST API-API.AX
- API INTENDS TO VIGOROUSLY DEFEND ACTION
- CLAIMS AGAINST IT WILL BE WITHDRAWN SUBJECT TO COURT APPROVAL IN COMING WEEKS
- DISCONTINUATION OF CLASS ACTION FILED AGAINST API AND PRICELINE IN VICTORIA'S SUPREME COURT
News: API Australian Pharmaceutical Industries Says Discontinuance Of Class Action Against
Add to My Watchlist
What is My Watchlist?